Informações de Merus NV

Mais detalhes de Merus NV Empresa

Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.



Código da empresaMRUS

Nome da EmpresaMerus NV

Data de listagemMay 19, 2016

CEODr. Sven Ante (Bill) Lundberg, M.D.

Número de funcionários260

Tipo de títulosOrdinary Share

Fim do ano fiscalMay 19

EndereçoYalelaan 62

CidadeUTRECHT

Bolsa de valoresNASDAQ Global Market Consolidated

PaísNetherlands

Código postal3584 CM

Telefone310302538800

Sitehttps://merus.nl/

Código da empresaMRUS

Data de listagemMay 19, 2016

CEODr. Sven Ante (Bill) Lundberg, M.D.

Executivos da empresa Merus NV



Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Sven Ante (Bill) Lundberg, M.D.

President, Chief Executive Officer, Executive Director

198.74K

+55.46%

Dr. Anand Mehra, M.D.

Non-Executive Independent Chairman of the Board

--

Mr. Peter B. Silverman, J.D.

Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal

--

Ms. Sherri Spear

Investor Relations and Corporate Communications

--

Mr. Jason Haddock

Director

--

Dr. Fabian Zohren, M.D., Ph.D

Chief Medical Officer

--

Dr. Maxine Gowen, Ph.D.

Non-Executive Independent Director

--

Mr. Leonard (Len) Kanavy

Non-Executive Independent Director

--

Dr. Victor Sandor, M.D.

Non-Executive Independent Director

--

Mr. Gregory D. (Greg) Perry

Chief Financial Officer

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Sven Ante (Bill) Lundberg, M.D.

President, Chief Executive Officer, Executive Director

198.74K

+55.46%

Dr. Anand Mehra, M.D.

Non-Executive Independent Chairman of the Board

--

Mr. Peter B. Silverman, J.D.

Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal

--

Ms. Sherri Spear

Investor Relations and Corporate Communications

--

Mr. Jason Haddock

Director

--

Dr. Fabian Zohren, M.D., Ph.D

Chief Medical Officer

--

Detalhamento da receita

Sem dados

Sem dados

Por Empresa

Por Região

Sem dados

Distribuição de ações

Atualizado em: sex, 15 de ago

Investidores

Tipos de investidores

Investidores

Proporção

Fidelity Management & Research Company LLC

8.20%

Paradigm BioCapital Advisors LP

5.65%

RTW Investments L.P.

5.27%

Wellington Management Company, LLP

4.91%

Commodore Capital LP

4.65%

Outro

71.32%

Investidores

Proporção

Fidelity Management & Research Company LLC

8.20%

Paradigm BioCapital Advisors LP

5.65%

RTW Investments L.P.

5.27%

Wellington Management Company, LLP

4.91%

Commodore Capital LP

4.65%

Outro

71.32%

Tipos de investidores

Investidores

Proporção

Investment Advisor/Hedge Fund

36.78%

Hedge Fund

34.50%

Investment Advisor

25.54%

Corporation

1.93%

Venture Capital

1.77%

Research Firm

1.13%

Private Equity

0.93%

Individual Investor

0.37%

Pension Fund

0.36%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

431

77.28M

101.92%

-5.29M

2025Q2

411

75.46M

99.77%

-10.50M

2025Q1

420

74.82M

101.12%

-10.15M

2024Q4

398

74.69M

108.18%

-7.45M

2024Q3

373

72.99M

107.03%

-6.71M

2024Q2

355

69.91M

103.77%

+7.77M

2024Q1

315

57.35M

97.63%

-5.32M

2023Q4

282

57.36M

99.41%

-5.55M

2023Q3

268

57.60M

100.50%

+2.76M

2023Q2

260

49.90M

100.83%

+114.35K

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

Fidelity Management & Research Company LLC

6.22M

8.2%

+593.98K

+10.56%

Jun 30, 2025

Paradigm BioCapital Advisors LP

4.28M

5.65%

+727.89K

+20.48%

Jun 30, 2025

RTW Investments L.P.

4.00M

5.28%

-168.84K

-4.05%

Jun 30, 2025

Wellington Management Company, LLP

3.73M

4.92%

-991.45K

-21.01%

Jun 30, 2025

Commodore Capital LP

3.52M

4.65%

-947.84K

-21.19%

Jun 30, 2025

Deerfield Management Company, L.P.

3.38M

4.47%

+210.70K

+6.64%

Jun 30, 2025

Avoro Capital Advisors LLC

3.16M

4.16%

+155.56K

+5.19%

Jun 30, 2025

T. Rowe Price Associates, Inc.

2.26M

2.98%

+1.17M

+106.44%

Jun 30, 2025

Holocene Advisors, LP

2.23M

2.94%

+351.62K

+18.77%

Jun 30, 2025

Westfield Capital Management Company, L.P.

2.04M

2.69%

+541.17K

+36.05%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: qui, 6 de nov

Nome

Proporção

Harbor Health Care ETF

4.61%

ALPS Medical Breakthroughs ETF

4.1%

Tema Oncology ETF

3.91%

AltShares Merger Arbitrage ETF

3.3%

NYLI Merger Arbitrage ETF

3.1%

Goldman Sachs Hedge Industry VIP ETF

2.89%

First Trust IPOX Europe Equity Opportunities ETF

2.59%

Simplify Health Care ETF

2.48%

Invesco Dorsey Wright Healthcare Momentum ETF

1.5%

AltShares Event-Driven ETF

1.39%

Ver Mais

Harbor Health Care ETF

Proporção4.61%

ALPS Medical Breakthroughs ETF

Proporção4.1%

Tema Oncology ETF

Proporção3.91%

AltShares Merger Arbitrage ETF

Proporção3.3%

NYLI Merger Arbitrage ETF

Proporção3.1%

Goldman Sachs Hedge Industry VIP ETF

Proporção2.89%

First Trust IPOX Europe Equity Opportunities ETF

Proporção2.59%

Simplify Health Care ETF

Proporção2.48%

Invesco Dorsey Wright Healthcare Momentum ETF

Proporção1.5%

AltShares Event-Driven ETF

Proporção1.39%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados